The Patient-Centered Outcomes Research Institute has approved $70 million for nine new patient-centered research projects.
The new studies will focus on conditions ranging from a type of very early-stage, localized breast cancer to diabetes, chronic lung disease and migraines.
[Also: PCORI adds $142M for big data research]
With these latest awards, PCORI has now approved or awarded more than $1.2 billion for research.
The new studies will compare: active surveillance to traditional treatments, effectiveness of two common medications for chronic obstructive pulmonary disease, varying approaches to smoking cessation among adults with mental illness, competing approaches to managing chronic migraines and the use of inhaled corticosteroid versus symptom-based use in treating asthma exacerbations.
PCORI is an independent, nonprofit organization authorized by Congress in 2010. Its mission is to fund research to provide patients, their caregivers, and clinicians with evidence-based information needed to make better-informed healthcare decisions.
[Like Healthcare IT News on Facebook]
PCORI also awarded $6.7 million to three members of PCORnet as part of its ongoing work to establish a national patient-centered clinical research network. That money will go toward studying population health policies and interventions for type II diabetes. The agency awarded another $5.2 million to researching the effectiveness of wellness coaches for African Americans with uncontrolled diabetes. And PCORI allocated $3.8 million for a study to determine the optimal dose of aspirin for preventing heart attacks and strokes.
Twitter: @HealthITNews
